The mission of the Office of Provider Engagement and Regulation (OPER) is to provide a
center of support for prescribers and dispensers to better promote professional education, informed clinical decision-making, best practices and innovation so that
Maryland patients experience optimal access, efficacy and safety in connection
with controlled substances.
OPER was formed February 2019 and consists of the Office of Controlled Substances Administration (OCSA) and the Prescription Drug Monitoring Program (PDMP).
The OCSA and the PDMP continue to prioritize all existing directives, and OPER
maintains all mandated requirements and restrictions related to data access.
For more information on the OCSA and PDMP, please click the links below
to the program websites.
OPER Director - Vacant
Deputy Director - Prescription Drug Monitoring Program
Deputy Director - Office of Controlled Substances Administration
Click on the images below to access websites.